WASHINGTON (dpa-AFX) - Boston Scientific Corp. (BSX) said it has launched the Precision Montage MRI Spinal Cord Stimulator or SCS System after receiving approval from the U.S. Food and Drug Administration or FDA.
The Precision Montage System offers customized relief to patients with chronic pain while also enabling safe access to full body magnetic resonance imaging or MRI in a 1.5 Tesla environment when conditions of use are met. Boston Scientific is introducing the system at the 8th World Congress of the World Institute of Pain in New York City on May 20 to 23, 2016.
The company noted that the new SCS system will expand the suite of Boston Scientific products that leverage the Illumina 3D algorithm, a three-dimensional anatomy-driven computer model designed for simple point-and-click pain targeting to support physicians in treating chronic pain.
In addition to the new Precision Montage MRI SCS System, the portfolio includes the Precision Spectra System, which is designed to provide broad coverage for pain with 32 contacts, and the Precision Novi System, the smallest high-capacity non-rechargeable device.
According to the company, the Lumina clinical study has demonstrated 70 percent greater low-back pain relief with the SCS system in the Illumina 3D family, which was maintained out to 24-months.
More than 100 million Americans suffer from chronic pain, which can have a devastating impact on quality of life. The Precision Montage MRI SCS System allows patients to undergo a full-body MRI while benefiting from the pain relief of MultiWave Technology. MultiWave Technology enables delivery of multiple waveforms, including burst and higher rates, intended to help respond to changes in pain over time.
Copyright RTT News/dpa-AFX